HAO1 and nephrocalcinosis: In this study, we demonstrated that a sustained reduction of GO protein expression could be achieved in PH1 mice through the administration of an AAV vector carrying both SaCas9 and Hao1-specific gRNAs, resulting in the reduction of oxalate production and prevention of nephrocalcinosis.